TransEnterix plans to conduct $50 million public offering of stock

Stifel, RBC are bookrunners; Ladenberg Thalmann, Raymond James assist

By Devika Patel

Knoxville, Tenn., April 2 - TransEnterix, Inc. will conduct a $50 million public sale of common stock with a greenshoe, according to a preliminary prospectus supplement filed Wednesday with the Securities and Exchange Commission.

Stifel, Nicolaus & Co. Inc. and RBC Capital Markets LLC are the joint bookrunning managers; Ladenberg Thalmann & Co. and Raymond James Financial Inc. are the co-managers.

Proceeds will be used for research and development, sales, marketing and commercialization related to the SurgiBot System, for working capital and for other general corporate purposes.

The medical device company is based in Morrisville, N.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.